- mabc307
Hyperactive Chemotaxis Contributes to AntiTNFα Treatment Resistance in Inflammatory Bowel Disease
Updated: Oct 26, 2021
Tung On Yau(1), Jayakumar Vadakekolathu(1), Benjamin Dickins(1), Christos Polytarchou(1), Sergio Rutella(1)
1. John Van Geest Cancer Research Centre, Nottingham Trent University, UK
Submitting Author: Tung On Yaul
Contact: payton.yau@ntu.ac.uk